Tenomix logo

About us

Tenomix is transforming pathology automation by uniting robotics, ultrasound imaging, and AI at the benchtop—an industry first. Their first product application focuses on the lymph node (LN) dissection process, which is essential for measuring cancer spread, yet it is still manually performed worldwide at an error rate of over 50%. Tenomix’s flagship device is designed to streamline and guide LN identification, subsequently helping pathology labs optimize workflow, conserve resources, and enhance overall consistency in tissue evaluation. Backed by a multidisciplinary team of engineers, clinicians, investors, and business leaders, Tenomix is forging strategic partnerships with leading healthcare providers and research institutions to refine and validate its novel approach. By innovating the LN dissection process, Tenomix aims to support pathology teams worldwide in their mission to improve cancer staging—ultimately empowering better-informed decisions in patient care.
Program engagement

Leadership:

Saumik Biswas

Co-Founder & CEO

Eveline Pasman

Co-Founder & COO

Sherif Abdou

Co-Founder & CBO

Michael Lavdas

Co-Founder and Director

Intellectual Property

Stage:

Sector:

Subsector:

Synapse Life Science Pitch Competition March 26, 2025 from 4:00pm - 8:00pm EDT

Get tickets for the 2025 Synapse Competition!

Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.

Why you should attend:

  • Meet the finalists at the 12th annual Synapse Competition showcase!
  • Discover emerging life science innovations
  • Network with industry leaders and Ontario’s thriving life science ecosystem.

March 26, 2025 | 4:00pm – 8:00pm EDT